
Reuters India
<img alt="" height="1" width="1" />
Merck Cholesterol Drug Lowers Heart Attack In Kidney Patients - Quick Facts
RTT News
(RTTNews) - Merck & Co. Inc. (MRK: News ), Saturday indicated that its cholesterol-lowering medicine Vytorin reduced the possibility of heart attack, stroke and other cardiovascular problems by 16.1% in chronic kidney disease patients, when compared to ...
Merck Drug Helps Kidney Patients In Study, But Questions LingerNASDAQ
Merck's Vytorin Safely Cuts Heart Risk in Kidney Patients, Research FindsBloomberg
Lowering Bad Cholesterol Reduced Heart Problems in Kidney Patients, Study ShowsNew York Times (blog)
MarketWatch (press release) -Reuters India -NewsyStocks.com
all 21 news articles »
More...